Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
When people lose weight rapidly using medications like semaglutide, one question echoes across online forums and doctor's offices: Will I lose muscle along with fat? Research shows that GLP-1 receptor agonists can indeed reduce muscle mass if proper countermeasures are not in place, though the effect varies significantly between individuals based on genetics, activity level, and nutritional support.
How GLP-1 Medications Affect Muscle During Weight Loss
Semaglutide and similar GLP-1 drugs work by slowing stomach emptying and reducing appetite signals in the brain. This powerful effect helps people eat less and lose weight—sometimes 15 to 22 percent of body weight in clinical trials. However, when calorie intake drops sharply, the body can break down both fat and muscle tissue for energy, a process called catabolism. Your body prefers to preserve fat stores and burn muscle when calories become scarce, which is why rapid weight loss without intervention often includes unwanted lean mass loss.
Studies tracking body composition changes in GLP-1 users show mixed results depending on study design and participant characteristics. A 2023 analysis found that people on semaglutide lost approximately 25 to 30 percent of their total weight loss as lean muscle tissue. This is higher than the 20 percent lean mass loss typical of standard calorie-restricted diets, suggesting GLP-1 medications amplify the muscle-loss risk. The good news: structured exercise and adequate protein intake can dramatically reduce or even eliminate this effect.
Protein Intake and Resistance Training: Your Muscle Shields
The most effective defense against muscle loss during GLP-1 therapy is a dual approach: adequate protein consumption combined with regular resistance exercise. Nutrition experts recommend increasing protein to 0.8 to 1.0 grams per pound of body weight when using appetite-suppressing medications, well above the standard 0.8 grams per kilogram guideline for sedentary adults. This higher intake ensures amino acids remain available for muscle protein synthesis rather than breaking down existing fibers. Adding protein-rich snacks, Greek yogurt, eggs, lean meats, and legumes throughout the day helps meet these elevated targets despite reduced appetite.
Resistance training—weightlifting, resistance bands, or bodyweight exercises—sends signals to your muscles telling them they are needed and worth preserving. People who strength train two to three times weekly while on semaglutide maintain 80 to 90 percent of their lean mass compared to those who only restrict calories. The combination becomes even more powerful: high protein plus resistance exercise can limit lean mass loss to just 5 to 10 percent of total weight lost, meaning most of your weight loss becomes actual fat reduction.
Individual Genetic Factors in Muscle Preservation
Not everyone's body responds identically to GLP-1 medications or to weight loss interventions. Genetic variations affect how efficiently your muscles respond to exercise, how your body partitions energy between fat and lean tissue, and how sensitive your metabolism is to calorie deficit. For instance, the FTO rs9939609 variant influences fat mass and metabolic rate, while the MC4R rs17782313 variant plays a role in appetite regulation and energy homeostasis. These genetic blueprints help explain why two people eating the same diet and exercising identically can experience different rates of muscle loss on the same semaglutide dose.
PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways and 150+ genetic insights including muscle-sparing variants. This test reveals your individual predisposition to lean mass loss and helps personalize nutrition and exercise recommendations. Understanding your genetic muscle-preservation profile allows your clinician to adjust protein targets, exercise intensity, and medication strategy to protect metabolic health. The test costs $99 as an add-on after your first month of treatment, giving you data-driven clarity about your unique biology.
Choosing Semaglutide With Muscle Loss in Mind
Semaglutide, available through PlexusDx as a compounded injection starting at $149 per month, can be an effective tool for weight loss when combined with intentional muscle-preservation strategies. Compounded semaglutide from licensed 503A pharmacies meets the same purity and potency standards as branded versions while remaining accessible without insurance across all 50 states. Your dose may need to go up as your body adapts, but your price won't—PlexusDx keeps monthly costs flat regardless of dose progression. This pricing transparency lets you focus on clinical outcomes rather than worrying about escalating costs.
The most successful long-term outcomes occur when patients adopt muscle-sparing practices from day one: setting a baseline strength-training routine, calculating adequate protein intake, and scheduling regular progress assessments. If you have specific concerns about muscle loss or want a personalized treatment plan informed by genetic testing, PlexusDx clinicians can review your individual risk factors and adjust your semaglutide strategy accordingly. Many patients find that structured support upfront prevents costly regaining of weight and rebuilding of muscle later.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Will I definitely lose muscle on semaglutide?
Muscle loss is not guaranteed and depends heavily on your exercise routine, protein intake, and genetics. Studies show that people who do resistance training and eat sufficient protein lose 80 to 90 percent less muscle during GLP-1 therapy compared to those who don't. Taking a proactive approach from the start significantly reduces this risk.
How much protein should I eat while taking semaglutide?
Aim for 0.8 to 1.0 grams of protein per pound of body weight daily, which is higher than standard recommendations. For a 200-pound person, that means roughly 160 to 200 grams per day. Spreading protein across meals and snacks helps maintain amino acid availability despite reduced appetite.
Can the Precision Peptide Genetic Test tell me if I'll lose muscle?
The PlexusDx Precision Peptide Genetic Test analyzes your FTO, MC4R, GLP1R, and GIPR genetic variants along with 145+ other insights that influence how your body handles weight loss and muscle preservation. This $99 add-on reveals your genetic predisposition to lean mass loss, allowing your clinician to customize your nutrition and exercise plan before problems arise.
How often should I do resistance training to protect muscle on semaglutide?
Two to three strength-training sessions per week is the evidence-based minimum for meaningful muscle preservation during GLP-1 therapy. Each session should include compound movements like squats, deadlifts, or push-ups that engage multiple muscle groups. Consistency matters more than intensity—regular moderate training outperforms sporadic heavy lifting.
Does the price of semaglutide at PlexusDx increase if I need a higher dose?
No. PlexusDx compounded semaglutide injection starts at $149 per month and remains at that price regardless of dose escalation. Your dose may need to go up as your body adjusts, but your price won't, making it easier to stay on treatment without financial surprises.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is There a Generic GLP-1? Exploring the Latest Developments in Weight Loss Medications
How to Relieve Nausea from Semaglutide: Practical Tips for a Smoother Experience